SOPH 3.59 SOPHiA GENETICS SA
| Range: | 2.7-7.37 | Vol Avg: | 52834 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 1.04 | Cap: | 0.23B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Jul 23 2021 | Empoloyees: | 430 | ||
| CUSIP: | H82027105 | CIK: | 0001840706 | ISIN: | CH1125843347 | Country: | CH |
| CEO: | Dr. Jurgi Camblong M.B.A., Ph.D. | Website: | https://www.sophiagenetics.com | ||||
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Stock Details
SOPH 5
Sophia Genetics downgraded to Equal Weight from Overweight at Morgan Stanley
Tejas Savant·Wed Aug 07 2024
Morgan Stanley
SOPH 6
Guggenheim Starts Sophia Genetics SA (SOPH) at Buy
Subbu Nambi·Thu Jun 27 2024
Guggenheim
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow